203 related articles for article (PubMed ID: 2499916)
1. Treatment modalities in superficial bladder cancer.
Irwin R; Zincke H; Droller MJ; Prout GR; Soloway MS
Semin Urol; 1989 Feb; 7(1 Suppl 1):1-12. PubMed ID: 2499916
[No Abstract] [Full Text] [Related]
2. Treatment of superficial carcinoma of the bladder.
Paulson DF
Prog Clin Biol Res; 1984; 162B():193-209. PubMed ID: 6209720
[No Abstract] [Full Text] [Related]
3. Intravesical chemotherapy.
Prout GR
Prog Clin Biol Res; 1984; 162B():125-50. PubMed ID: 6438639
[No Abstract] [Full Text] [Related]
4. Rationale for intravesical chemotherapy in the treatment and prophylaxis of superficial transitional cell carcinoma.
Soloway MS; Jordan AM; Murphy WM
Prog Clin Biol Res; 1989; 310():215-36. PubMed ID: 2505268
[TBL] [Abstract][Full Text] [Related]
5. Current concepts in the management of superficial bladder cancer.
Soloway MS
Arch Esp Urol; 1990; 43 Suppl 2():115-21. PubMed ID: 2129003
[No Abstract] [Full Text] [Related]
6. Intravesical chemotherapy versus immunotherapy for superficial bladder cancer.
Huben RP
Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):17-22. PubMed ID: 8727806
[TBL] [Abstract][Full Text] [Related]
7. Intravesical chemotherapy: how effective is it?
Heney NM
Urology; 1988 Mar; 31(3 Suppl):17-9. PubMed ID: 3126591
[TBL] [Abstract][Full Text] [Related]
8. Managing superficial bladder cancer: an overview.
Soloway MS
Urology; 1992 Dec; 40(6 Suppl):5-10. PubMed ID: 1466119
[TBL] [Abstract][Full Text] [Related]
9. Surgery and intravesical chemotherapy in the management of superficial bladder cancer.
Soloway MS
Semin Urol; 1983 Feb; 1(1):23-33. PubMed ID: 6433424
[No Abstract] [Full Text] [Related]
10. Introduction and overview of intravesical therapy for superficial bladder cancer.
Soloway MS
Urology; 1988 Mar; 31(3 Suppl):5-16. PubMed ID: 3126593
[TBL] [Abstract][Full Text] [Related]
11. Superficial bladder disease: case studies and therapeutic advances.
Soloway MS; Droller MJ; Flanigan RC; Nseyo UO
Urology; 1992 Dec; 40(6 Suppl):11-22. PubMed ID: 1466118
[No Abstract] [Full Text] [Related]
12. BCG-RIVM intravesical immunoprophylaxis for superficial bladder cancer.
Debruyne FM; van der Meijden AP; Schreinemachers LM; Geboers AD; Franssen MP; van Leeuwen MJ; Steerenberg PA; de Jong WH; Ruitenberg EJ
Prog Clin Biol Res; 1988; 269():511-24. PubMed ID: 3134662
[No Abstract] [Full Text] [Related]
13. BCG versus thiotepa in non-CIS, stage Ta, T1 bladder cancer: rationale and design of ECOG trial.
Fisher HA
Prog Clin Biol Res; 1989; 310():275-83. PubMed ID: 2505271
[No Abstract] [Full Text] [Related]
14. BCG-(RIVM) versus mitomycin intravesical therapy in patients with superficial bladder cancer. EORTC GU Group and the Dutch South-East Collaborative Group.
Debruyne FM; van der Meijden AP; Franssen MP
Prog Clin Biol Res; 1989; 303():435-46. PubMed ID: 2506556
[No Abstract] [Full Text] [Related]
15. Intravesical therapy comparing BCG, adriamycin, and thiotepa in 200 patients with superficial bladder cancer: a randomized prospective study.
Martinez-Pineiro JA; Jimenez León J; Martinez-Pineiro L; Fiter L; Mosteiro JA; Navarro J; García Matres MJ; Cárcamo P
Prog Clin Biol Res; 1989; 310():237-52. PubMed ID: 2505269
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant intravesical therapy for superficial bladder cancer.
Batts CN
Ann Pharmacother; 1992 Oct; 26(10):1270-6. PubMed ID: 1421654
[TBL] [Abstract][Full Text] [Related]
17. Management of superficial transitional cell carcinoma of the bladder.
Fleischmann J; Goldberg G
Semin Urol; 1993 Nov; 11(4):193-204. PubMed ID: 8290825
[TBL] [Abstract][Full Text] [Related]
18. [Treatment and follow-up of superficial bladder cancer].
Raitanen M
Duodecim; 2002; 118(9):903-9. PubMed ID: 12238168
[No Abstract] [Full Text] [Related]
19. Bacillus Calmette-Guerin for treatment of superficial transitional cell carcinoma of the bladder in patients who have failed thiotepa and/or mitomycin C.
Soloway MS; Perry A
J Urol; 1987 May; 137(5):871-3. PubMed ID: 3106653
[TBL] [Abstract][Full Text] [Related]
20. Intravesical therapy for superficial bladder cancer.
Malkowicz SB
Semin Urol Oncol; 2000 Nov; 18(4):280-8. PubMed ID: 11101091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]